HCA Healthcare, Inc. $HCA Shares Purchased by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 31.0% during the fourth quarter, Holdings Channel.com reports. The firm owned 50,139 shares of the company’s stock after purchasing an additional 11,873 shares during the quarter. Exchange Traded Concepts LLC’s holdings in HCA Healthcare were worth $23,408,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Sovran Advisors LLC grew its holdings in HCA Healthcare by 1.0% during the 3rd quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock worth $1,063,000 after acquiring an additional 22 shares in the last quarter. Centerpoint Advisors LLC lifted its position in shares of HCA Healthcare by 11.0% during the 3rd quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock worth $95,000 after purchasing an additional 22 shares during the last quarter. Cary Street Partners Financial LLC increased its holdings in HCA Healthcare by 3.9% in the third quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock valued at $251,000 after buying an additional 22 shares during the last quarter. Angeles Wealth Management LLC lifted its holdings in HCA Healthcare by 2.4% during the 3rd quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock worth $432,000 after buying an additional 24 shares during the last quarter. Finally, One Capital Management LLC increased its holdings in shares of HCA Healthcare by 1.1% in the 3rd quarter. One Capital Management LLC now owns 2,250 shares of the company’s stock valued at $959,000 after acquiring an additional 24 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In related news, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares of the company’s stock, valued at $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the sale, the executive vice president directly owned 8,853 shares in the company, valued at $4,721,924.61. This represents a 16.06% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 15,214 shares of company stock valued at $7,797,595. Corporate insiders own 1.50% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $472.47 on Friday. The company’s fifty day moving average is $510.69 and its two-hundred day moving average is $475.54. HCA Healthcare, Inc. has a 1 year low of $314.43 and a 1 year high of $556.52. The company has a market capitalization of $105.63 billion, a P/E ratio of 16.65, a PEG ratio of 1.47 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. The business had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.99%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. UBS Group upped their price target on HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Wells Fargo & Company upped their target price on shares of HCA Healthcare from $452.00 to $481.00 and gave the company an “equal weight” rating in a report on Friday, January 30th. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. Barclays raised their price objective on HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a report on Wednesday, January 28th. Finally, Wall Street Zen downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 14th. Sixteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $537.73.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.